Emerald Health Bioceuticals Inc. — Form D
Emerald Health Bioceuticals Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-27. The offering totals $24K, of which $24K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-07-27
- Form: D
- Accession: 0001713164-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $24K
- Amount sold: $24K
- Investors: 3
- Date of first sale: 2017-07-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-291607
Issuer
- Name: Emerald Health Bioceuticals Inc.
- CIK: 0001713164
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 5910 PACIFIC CENTER BLVD, SUITE 300, SAN DIEGO, CA, 92121
- Phone: 1-858-947-8269
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Punit Dhillon | Director | San Diego, CA |
| Jim Heppell | Director | Vancouver, A1 |
| Gaetano Morello | Director | Vancouver, A1 |
| Gaetano Morello | Executive Officer | Vancouver, A1 |
| Jill Broadfoot | Executive Officer | Hayward, CA |
| Tu Diep | Executive Officer | San Diego, CA |
| Margaret Dalesamdro | Director | San Diego, CA |
| Elena Traistaru | Executive Officer | San Diego, CA |
| Dr. Avtar Dhillon | Director | San Diego, CA |
| Dr. Avtar Dhillon | Executive Officer | San Diego, CA |
| Jade Beutler | Executive Officer | San Diego, CA |
| Dr. Gaetano Morello | Director | San Diego, CA |
Other filings by this issuer (2)
More